A Phase I/II Trial of Proton Therapy With Concurrent Capecitabine for Locally Advanced and Recurrent Rectal Cancer.
Withdrawn prior to enrolment
Phase of Trial: Phase I/II
Latest Information Update: 21 Mar 2012
At a glance
- Drugs Capecitabine (Primary)
- Indications Rectal cancer
- Focus Adverse reactions; Therapeutic Use
- 30 Aug 2010 Status changed from active, no longer recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
- 26 Sep 2008 Added end date, from clinicaltrials.gov record.
- 26 Sep 2008 Status changed from recruiting to active, no longer recruiting, according to clinicaltrials.gov record.